drugset / Trial / NCT05498012

CBD Effects on Periodontal Health of Patients With Chronic Periodontitis

NCT05498012

Phase 1/2 Completed 90 enrolled Palacky University CB21 Pharma Ltd. · collab
RandomizedParallel-groupDouble-blindSupportive care

Summary

The suppression of chronic periodontitis after application of dental gel and toothpaste containing cannabidiol (CBD) will be evaluated.

Timeline

Start
2020-11-05
Primary completion
2022-01-27
Completion
2022-02-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 1 % Topical
Subject chlorhexidini digluconatis Unknown 1 % Topical

Indications